Delivery Order 75N94020D00016-75N94020F00001

Award Date 8/1/20
Potential Completion Date 7/31/25
Potential Value $81K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Portland, OR 97239, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
18
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Oregon Health & Science University (OHSU), a U.S. state government, educational institution, and state-controlled institution of higher learning. The $133,612.31 contract is for the provision of assistance in protocol review, protocol development, and activities associated with the past, present, and future of the Contraceptive Clinical Trials Network (CCTN)...
This federal contract award was made by the National Institute of Child Health and Human Development, a civilian agency, to Oregon Health & Science University (OHSU) for a Contraceptive Clinical Trial. The contract has a ceiling value of $653,663.79 and is a Delivery Order with a Cost No Fee pricing type. The contract does not have a set-aside designation. OHSU is a major research university and academic medical center that frequently receives federal funding through contracts and grants,...
This is a delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Oregon Health & Science University (OHSU) for the clinical evaluation of novel female contraception products. The contract has a period of performance from November 9, 2015 to November 8, 2018, with an ultimate completion date of September 30, 2022. The contract is a firm fixed price award with a ceiling value of $160,379.14. It does not have a set-aside...
The National Institute of Child Health and Human Development (NICHD) awarded a $444,793.00 cost-no-fee delivery order contract to Oregon Health & Science University (OHSU) to provide a central laboratory for pharmacokinetic and pharmacodynamic evaluation of levonorgestrel butanoate for female contraception. This contract is part of NICHD's Contraceptive Development Program and Contraceptive Clinical Trials Network. The contract has a period of performance through February 8, 2026 and does...
This federal contract award, with a ceiling value of $685,003.00, was issued by the National Institute of Child Health and Human Development (NICHD) to Oregon Health & Science University (OHSU) for the "Clinical Evaluation of Long-Acting Reversible Contraceptives." The period of performance is from September 25, 2015 to September 24, 2018, with an ultimate completion date of March 1, 2024. This contract is not designated as a set-aside. OHSU, a prominent research university and...
The U.S. National Institute of Child Health and Human Development (NICHD) awarded a $622,909.06 cost-no-fee delivery order contract to Oregon Health & Science University (OHSU) for a pharmacokinetic/pharmacodynamic evaluation of levonorgestrel butanoate for female contraception. The contract has a completion date of July 14, 2025 and does not have a set-aside designation. OHSU is a prominent research university and academic medical center based in Portland, Oregon that regularly receives...
This is a federal contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Oregon Health & Science University (OHSU) for an open-label trial on the efficacy, cycle control, and safety of a contraceptive vaginal ring delivering a daily dose of Nestorone and ethinyl estradiol. The contract has a ceiling value of $1,406,546.35 and does not have a set-aside designation. OHSU is a prominent research university and academic medical center that...
This federal contract award is for the finalization of the protocol, regulatory approval, start-up, and commencement of recruitment, screening, and enrollment for the Ovaprene vaginal device clinical trial. The contract, valued at $251,482.00, was awarded by the National Institute of Child Health and Human Development (NICHD) to Oregon Health & Science University (OHSU), a state-controlled institution of higher learning. The contract is a Delivery Order with a Cost No Fee pricing type, and...
The U.S. National Institute of Child Health and Human Development (NICHD) awarded a $79,934 delivery order contract to The Johns Hopkins University to provide support for the Contraceptive Clinical Trials Network (CCTN). The contract, which has a period of performance through July 2027, involves assisting with protocol review, protocol development, and past, present, and future CCTN clinical trial activities. This delivery order award is part of the larger "Contraceptive Development Program...
This is a delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services (HHS), to the University of Cincinnati to provide assistance with protocol review, development, and activities related to the Contraceptive Clinical Trials Network (CCTN) female sites. The contract has a ceiling value of $103,931.34 and runs through June 25, 2020. It is not designated as a set-aside...
  • 75N94020D00016
    Indefinite Delivery Contract
  • 75N94020D00016-75N94020F00001
    Delivery Order

This is a federal contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Oregon Health & Science University (OHSU) to provide services related to protocol review, protocol development, and activities associated with the NICHD Contraceptive Clinical Trials Network (CCTN). The contract has a ceiling value of $81,367.65 and a period of performance through July 31, 2025. It is a delivery order contract with a cost-no-fee pricing type and does not have a set-aside designation. OHSU is a prominent research university with extensive expertise in medical research and clinical trials. The contract supports NICHD's efforts to develop new contraceptive products, leveraging OHSU's capabilities in this domain.

Generated 2/19/25, 9:18 AM